Tilray Brands (TLRY)
(Delayed Data from NSDQ)
$1.63 USD
+0.04 (2.52%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $1.62 -0.01 (-0.61%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth C Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$1.63 USD
+0.04 (2.52%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $1.62 -0.01 (-0.61%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth C Momentum D VGM
Zacks News
Tilray, Inc. (TLRY) Stock Moves -1.18%: What You Should Know
by Zacks Equity Research
In the latest trading session, Tilray, Inc. (TLRY) closed at $6.68, marking a -1.18% move from the previous day.
Tilray (TLRY) in Focus: Stock Moves 9.6% Higher
by Zacks Equity Research
Tilray (TLRY) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.
Are Marijuana Stocks & ETFs Coronavirus-Proof?
by Sanghamitra Saha
Marijuana companies are witnessing robust demand amid the coronavirus outbreak. Time to buy some earlier-battered marijuana stocks and ETFs?
Do Options Traders Know Something About Tilray (TLRY) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Tilray (TLRY) stock based on the movements in the options market lately.
Company News for Mar 4, 2020
by Zacks Equity Research
Companies in the news are: SCON, OMER, QGEN, TLRY
Tilray, Inc. (TLRY) Reports Q4 Loss, Misses Revenue Estimates
by Zacks Equity Research
Tilray, Inc. (TLRY) delivered earnings and revenue surprises of -82.35% and -15.20%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Tilray (TLRY) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Investors will focus on revenue growth and other pipeline updates, when Tilray (TLRY) reports fourth-quarter 2019 results.
Implied Volatility Surging for Tilray (TLRY) Stock Options
by Payel Dhar
Investors need to pay close attention to Tilray (TLRY) stock based on the movements in the options market lately.
What Do Canopy Earnings Say About Cannabis ETFs?
by Sanghamitra Saha
Solid earnings drive Canopy Growth stock and boost the industry as a result. Is it right time to buy marijuana ETFs?
Tilray, Inc. (TLRY) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Tilray, Inc. (TLRY) closed at $17.78 in the latest trading session, marking a +1.08% move from the prior day.
Zacks Market Edge Highlights: Amazon, Tesla, Beyond Meat, Ferrari and Tilray
by Zacks Equity Research
Zacks Market Edge Highlights: Amazon, Tesla, Beyond Meat, Ferrari and Tilray
Tesla Euphoria: Signal of a Market Top?
by Tracey Ryniec
With Tesla price targets flying high, some investors are having flashbacks to analyst upgrades on Amazon in 1998 that signaled an overheated stock market.
Tilray, Inc. (TLRY) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Tilray, Inc. (TLRY) closed at $19.22, marking a +1.53% move from the previous day.
Options Traders Expect Huge Moves in Tilray (TLRY) Stock
by Zacks Equity Research
Investors need to pay close attention to Tilray (TLRY) stock based on the movements in the options market lately.
Tilray (TLRY) in Focus: Stock Moves 9% Higher
by Zacks Equity Research
Tilray (TLRY) shares rose 9% in the last trading session, amid huge volumes.
5 Cheap Stocks Trading Under $20 to Buy for 2020
by Benjamin Rains
Let's dive into five strong stocks currently trading for under $20 per share we found with our Zacks Stock Screener that investors might want to buy for 2020...
Ride the Cannabis Wave With These 3 Stocks
by Urmimala Biswas
Here we discuss three best stocks in the emerging cannabis space.
Do Options Traders Know Something About Tilray (TLRY) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Tilray (TLRY) stock based on the movements in the options market lately.
Is REX Shares' Leveraged Cannabis ETN Launch Untimely?
by Sanghamitra Saha
REX Shares has launched two cannabis-related ETNs, one among which is double leveraged. Is the launch untimely?
Tilray (TLRY) Looks Good: Stock Adds 7.2% in Session
by Zacks Equity Research
Tilray (TLRY) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.
Marijuana ETFs Bounce Back: Can the Rally Last?
by Sanghamitra Saha
Passing of a legalization bill by a U.S. congressional committee boosted the battered marijuana ETF space lately.
What's in the Cards for OrganiGram (OGI) in Q4 Earnings?
by Zacks Equity Research
According to OrganiGram (OGI), there is hugely unmet consumer demand for CBD products.
The Zacks Analyst Blog Highlights: Tilray, Canopy Growth and Aurora Cannabis
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Tilray, Canopy Growth and Aurora Cannabis
Can Bill Hopes Relieve Earnings-Induced Pain in Pot ETFs?
by Sanghamitra Saha
A wave of disappointing earnings caused a bloodbath in marijuana ETFs last week. However, talks of an end to the federal embargo on marijuana could turn this segment around.
Implied Volatility Surging for Tilray (TLRY) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Tilray (TLRY) stock based on the movements in the options market lately.